Labshake search
Citations for Haematologic Technologies :
1 - 7 of 7 citations for Polybrominated Diphenyl Ether Predominant Congener Mixture 1 100 Dilution Unlabeled since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2023Quote: ... depleted plasma was supplemented with purified FXI (100 pM; Haematologic Technologies) or FXII (1.2 nM ...
-
bioRxiv - Bioengineering 2021Quote: ... and tPA-beads (105 and 106/μL) were incubated with excess (100 μM) fluorogenic substrate for tPA (SN-18, Haematologic Technologies Inc., Essex Junction, VT). For solvated tPA experiments ...
-
bioRxiv - Neuroscience 2024Quote: ... a glass pipette was inserted into the lumen of the MCA and 1 μL of thrombin (1 UI; HCT-0020, Haematologic Technologies Inc) was injected to induce in situ clot formation (Fig ...
-
bioRxiv - Cell Biology 2021Quote: ... BOECs were stimulated with 1 U/ml human α-thrombin (HCT-0020, Haematologic technologies) diluted in phosphate-buffered saline.
-
bioRxiv - Neuroscience 2023Quote: ... 1 μl of purified human alpha-thrombin (1UI; HCT-0020, Haematologic Technologies Inc., USA) was injected into the MCA with a glass pipette ...
-
bioRxiv - Neuroscience 2019Quote: ... the eye cup was treated for ∼ 15 minutes with human plasmin (∼ 50 µg mL−1, Sigma or Haematologic Technologies) to aid vitreous removal.
-
bioRxiv - Pathology 2020Quote: ... membranes were incubated overnight at 1:2000 in primary antibody (Anti-murine Prothrombin, Haematologic Technologies Inc, Essex Junction, VT) followed by corresponding secondary antibody conjugated to horseradish peroxidase ...